High-dimensional immunoprofiling can rationally inform how immunotherapy treatments and vaccines affect and modulate the immune response over time by identifying and quantifying large numbers of different immune cell subsets within blood or tissue samples.
To learn more, sign up to receive notifications about immunoSCAPE’s new high-dimensional analysis webinar series.
Presented by Michael Fehlings, Ph.D., co-founder and Director, Scientific Affairs, immunoSCAPE, the first webinar discussed high-dimensional immunoprofiling citing results from several peer-reviewed publications.